🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
William E. Gooding

William E. Gooding

Cancer Research And Biostatistics

ORCID: 0000-0001-9070-3559

Also affiliated with UPMC Hillman Cancer Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 13 papers. Top paper: “Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity”.

Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3659

N/A

1.7DataRank · unranked

34 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Neoadjuvant nivolumab alone or in combination with relatlimab or ipilimumab in resectable head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6018

N/A

0.695DataRank · unranked

17 citations

William E. Gooding, Simion I. Chiosea, Umamaheswar Duvvuri, Seungwon Kim, Mark Kubik +8 more

Erlotinib, Erlotinib–Sulindac versus Placebo: A Randomized, Double-Blind, Placebo-Controlled Window Trial in Operable Head and Neck Cancer

Clinical Cancer Research(2014)10.1158/1078-0432.ccr-13-3360

N/A

0.598DataRank · unranked

53 citations

Julie E. Bauman, William E. Gooding, William Denq, Sufi M. Thomas, Lin Wang +14 more

Expression of lymphoid structure-associated cytokine/chemokine gene transcripts in tumor and protein in serum are prognostic of melanoma patient outcomes

Frontiers in Immunology(2023)10.3389/fimmu.2023.1171978

N/A

0.360DataRank · unranked

10 citations

Hassan Abushukair, Aofei Li, Andrew Knight, Ayah Nedal Al Bzour, Ian MacFawn +16 more

Phase II trial of adjuvant de-escalated radiation + adjuvant nivolumab for intermediate-high risk P16+ oropharynx cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6014

N/A

0.104DataRank · unranked

1 citations

Dan P. Zandberg, Adam Raben, Shaum Sridharan, Mark Kubik, José P. Zevallos +6 more

Evaluation of electromagnetic navigational bronchoscopic biopsy of lung lesions performed by a thoracic surgical service

Surgery(2023)10.1016/j.surg.2022.11.036

N/A

0DataRank · unranked

6 citations

Arjun Pennathur, Daniel Brynien, James D. Luketich, Mark Scaife, David G. Azar +4 more

Risk assessment for distant metastasis in differentiated thyroid cancer using molecular profiling: A matched case‐control study

Cancer(2021)10.1002/cncr.33421

N/A

0DataRank · unranked

75 citations

William E. Gooding, Alyaksandr V. Nikitski, Abigail I. Wald, Sally E. Carty, Esra Karslioglu French +6 more

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676

N/A

0DataRank · unranked

0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Data from Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 Immunity

(2023)10.1158/1078-0432.c.6532676.v1

N/A

0DataRank · unranked

0 citations

Haider Mahdi, Yusi Fang, Mary Strange, Ibrahim Uygun, Mainpal Rana +11 more

Image-guided radiofrequency ablation for treatment of stage I non–small cell lung cancer in 111 high-risk patients: Analysis of prognostic variables

Journal of Thoracic and Cardiovascular Surgery(2025)10.1016/j.jtcvs.2025.08.015

N/A

0DataRank · unranked

2 citations

James D. Luketich, Matthew J. Schuchert, Anna L. Slingerland, William E. Gooding, John P. Ryan +6 more

An alternative approach to repair of giant paraesophageal hernia in selected patients with minimal history of reflux: Analysis of outcomes in more than 100 patients

JTCVS Open(2025)10.1016/j.xjon.2025.04.019

N/A

0DataRank · unranked

0 citations

James D. Luketich, Edgar Aranda‐Michel, Nicholas E. Baker, Evan T. Alicuben, Ryan M. Levy +8 more

Analysis of outcomes of reoperative fundoplication in more than 500 patients after failed primary antireflux surgery: Experience over two decades

Journal of Thoracic and Cardiovascular Surgery(2025)10.1016/j.jtcvs.2025.06.024

N/A

0DataRank · unranked

0 citations

James D. Luketich, Claire Collison, Victor Crentsil, Nandini Doshi, Brittany Quattrone +8 more

Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases

Annals of Surgical Oncology(2021)10.1245/s10434-020-09464-9

N/A

0DataRank · unranked

27 citations

Haroon A. Choudry, Heather Jones, Mark D. Girgis, William E. Gooding, Paweł Kaliński +2 more